TRANS-4-(1-NAPHTHYL)PYRROLIDINE-3-CARBOXYLIC ACID HCL, 95.0%, 250mg

[4-(4-Fluorobenzyl)morpholin-2-yl]methylamine, 97.0%, 10g

3-(furan-2-yl)-1H-pyrazole-5-carbohydrazide, 95+%, 1g

(S,E)-1-(3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)vinyl)-1H-indol-1-yl)ethan-1-one, 98%, 50mg

(R)-4-((9H-fluoren-9-yl)methoxy)-2-((tert-butoxycarbonyl)amino)-4-oxobutanoic acid, 97%, 250mg

2-Bromo-9,9-diethylfluorene>98.0%(GC)1g

Ethyl 3-methylpiperidine-3-carboxylate hydrochloride, 95.0%, 250mg

Naphthalene-1,3,5-trisulfonic acid, sodium salt(1:1), 95.0%, 5g

6-Bromo-8-fluoroimidazo[1,2-a]pyridine-2-carboxylic acid, 95.0%, 100mg

1-(4-Bromobutoxy)-4-chlorobenzene, 97%, 5g

Ethyl 6-Bromohexanoate>98.0%(GC)25g

1-(3,4-difluorobenzoyl)azetidine-3-carboxylic acid, 95.0%, 250mg

1-(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethanone, 95.0%, 1g